Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2007;100:296-298
doi: 10.1161/01.RES.0000259326.68260.20
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sipido, K. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sipido, K. R.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*CAFFEINE
*CALCIUM COMPOUNDS
*CALCIUM, ELEMENTAL
*SODIUM
Related Collections
Right arrowRelated Article
(Circulation Research. 2007;100:296.)
© 2007 American Heart Association, Inc.


Editorials

CaM or cAMP

Linking ß-Adrenergic Stimulation to ‘Leaky’ RyRs

Karin R. Sipido

From the Laboratory of Experimental Cardiology, University of Leuven, Belgium.

Correspondence to Karin R. Sipido, MD, PhD, Laboratory of Experimental Cardiology, KUL, Campus Gasthuisberg O/N 7th floor, Herestraat 49, B-3000 Leuven, Belgium. E-mail Karin.Sipido@med.kuleuven.ac.be



See related article, pages 391–398


Key Words: Ca-calmodulin kinase • sarcoplasmic reticulum • heart failure • arrhythmias • ryanodine receptor • adrenergic receptor


An extract of the first 250 words of the full text is provided, because this article has no abstract.
 


*    Introduction
 
During each heart beat a transient rise in [Ca2+]i links the electrical signal to the actual contraction. Ca2+ release from the sarcoplasmic reticulum (SR) is the major source of this Ca2+ transient and occurs through the ryanodine receptor, RyR. The RyR is a Ca2+-activated channel, responding to Ca2+ influx, commonly referred to as the trigger Ca2+, predominantly through the L-type Ca2+ channel. The Ca2+ available in the SR is the SR Ca2+ content or Ca2+ load. The SR Ca2+ content depends to a large extent on the Ca2+ uptake into the SR by SERCA, regulated by phospholamban, and also on the balance of Ca2+ fluxes across the sarcolemma. For the latter, the Na+/Ca2+ exchanger is the major efflux pathway, generating an inward current. Alterations in [Ca2+]i handling have been implicated in contractile dysfunction in heart failure, and several proteins are involved such as SERCA, phospholamban and the Na+/Ca2+ exchanger, which would all influence the available Ca2+ in the SR.

When Marks et al reported in 2000 that hyperphosphorylation of the ryanodine receptor (RyR) could underlie abnormal calcium cycling in heart failure,1 it was the start of a new area of research that has since sparked a lot of debate. Increased phosphorylation was proposed to lead to reduced binding of the stabilizing protein, FKBP12.6 or calstabin, and result in increased channel openings or ‘leaky’ RyRs. This will lead to abnormal release of Ca2+ in diastole as well as abnormal gating during excitation-contraction coupling. The abnormal . . . [Full Text of this Article]


Related Article:

ß-Adrenergic Enhancement of Sarcoplasmic Reticulum Calcium Leak in Cardiac Myocytes Is Mediated by Calcium/Calmodulin-Dependent Protein Kinase
Jerald Curran, Mark J. Hinton, Eduardo Ríos, Donald M. Bers, and Thomas R. Shannon
Circ. Res. 2007 100: 391-398. [Abstract] [Full Text] [PDF]



This article has been cited by other articles:


Home page
Eur Heart JHome page
N. Hamdani, W. J. Paulus, L. van Heerebeek, A. Borbely, N. M. Boontje, M. J. Zuidwijk, J. G.F. Bronzwaer, W. S. Simonides, H. W. M. Niessen, G. J. M. Stienen, et al.
Distinct myocardial effects of beta-blocker therapy in heart failure with normal and reduced left ventricular ejection fraction
Eur. Heart J., August 1, 2009; 30(15): 1863 - 1872.
[Abstract] [Full Text] [PDF]


Home page
PhysiologyHome page
Y. Ikeda, M. Hoshijima, and K. R. Chien
Toward Biologically Targeted Therapy of Calcium Cycling Defects in Heart Failure
Physiology, February 1, 2008; 23(1): 6 - 16.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
C. H. George
Sarcoplasmic reticulum Ca2+ leak in heart failure: mere observation or functional relevance?
Cardiovasc Res, January 15, 2008; 77(2): 302 - 314.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
L. A. Venetucci, A. W. Trafford, S. C. O'Neill, and D. A. Eisner
The sarcoplasmic reticulum and arrhythmogenic calcium release
Cardiovasc Res, January 15, 2008; 77(2): 285 - 292.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J. A. K. Birkeland, F. Swift, N. Tovsrud, U. Enger, P. K. Lunde, E. Qvigstad, F. O. Levy, O. M. Sejersted, and I. Sjaastad
Serotonin increases L-type Ca2+ current and SR Ca2+ content through 5-HT4 receptors in failing rat ventricular cardiomyocytes
Am J Physiol Heart Circ Physiol, October 1, 2007; 293(4): H2367 - H2376.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
T. R. Shannon
Linking Calsequestrin to Lumenal Control of SR Ca2+ Release
Circ. Res., September 14, 2007; 101(6): 539 - 541.
[Full Text] [PDF]